Healthcare / Medical - Equipment & ServicesUpdated 2026-05-10 22:07 UTC

LON/0QK8 stock hub

LON/0QK8 has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0QK8is not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

6.8B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0QK8

In the news

Latest news · LON/0QK8

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E9.1

P25 12.9P50 16.9P75 23.5

Trailing P/En/a

P25 15.9P50 22.9P75 35.8

ROE-15

P25 -54.2P50 2.1P75 13.7

ROIC6.8

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0QK8 market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

212

Groups with data

Currency

USD

Showing 212 of 212 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	37,500
Employees Change	-22,000%
Employees Change Percent	-36.67
Enterprise value	$12.4B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Equipment & Services
Isin	US0718131099
Last refreshed	2026-05-10
Market cap	$6.8B
Price	$17.35
Price currency	USD
Rev Per Employee	228,605.14x
Sector	Healthcare
Sic	3841
Symbol	lon/0QK8
Website	https://www.baxter.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-12.19%
EV Earnings	-14.95x
EV/EBIT	18.05x
EV/EBITDA	8.33x
EV/FCF	22.7x
EV/Sales	1.5x
FCF yield	8.03%
Forward P/E	9.08x
P/B ratio	1.5x
P/S ratio	0.8x
PE Ratio10 Y	34.53x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	8.29%
EBITDA Margin	16.86%
FCF margin	6.39%
Gross margin	34.65%
Gross Profit	$3B
Gross Profit Growth	-7.28%
Gross Profit Growth Q	-9.66%
Gross Profit Growth3 Y	-10.99%
Gross Profit Growth5 Y	-3.64%
Net Income	$-831.5M
Net Income Growth Years	0%
Pretax Margin	-4.49%
Profit Margin	-9.7%
Profit Per Employee	$-22,174
ROA	2.85
Roa5y	2.55
ROCE	5.81
ROE	-15.01
Roe5y	-9.06
ROIC	6.8
Roic5y	5.41

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-42.15%
Cagr3y	-25.94%
Cagr5y	-26%
Div CAGR10	-7.37%
Div CAGR3	-34.74%
Div CAGR5	-18.3%
EPS Growth Years	0
FCF Growth	252.68%
FCF Growth3 Y	-4.76%
FCF Growth5 Y	-10.59%
OCF Growth	88.69%
OCF Growth10 Y	-0.7%
OCF Growth3 Y	-5.49%
OCF Growth5 Y	-8.71%
Revenue Growth	5.1x
Revenue Growth Q	2.9x
Revenue Growth Quarters	3x
Revenue Growth Years	1x
Revenue Growth3 Y	-7.84x
Revenue Growth5 Y	-0.86x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.55
Assets	$15B
Cash	$1.5B
Current Assets	$5B
Current Liabilities	$2.7B
Debt	$7.3B
Debt EBITDA	$4.76
Debt Equity	$1.61
Debt FCF	$13.4
Equity	$4.6B
Interest Coverage	3.27
Liabilities	$10.5B
Long Term Assets	$10B
Long Term Liabilities	$7.8B
Net Cash	$-5.8B
Net Cash By Market Cap	$-85.19
Net Debt EBITDA	$4.02
Net Debt Equity	$1.27
Net Debt FCF	$10.61
Tangible Book Value	$-2.3B
Tangible Book Value Per Share	$-4.51
WACC	4.91

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.85
Inventory Turnover	3.3
Net Working Capital	$1.5B
Quick ratio	1.02
Working Capital	$2.4B
Working Capital Turnover	$2.56

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.54%
Dividend Growth	-62.79%
Dividend Growth Years	0%
Dividend per share	$0.27
Dividend Years	14
Dividend Yield	1.54%
Ex Div Date	2026-02-27
Last Dividend	$0.01
Payout Frequency	Quarterly

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-42.12%
200-day SMA	20.57
3Y total return	-59.39%
50-day SMA	17.62
50-day SMA vs 200-day SMA	50under200
5Y total return	-77.8%
All Time High	89.6
All Time High Change	-80.64%
All Time High Date	2022-02-09
All Time Low	15.74
All Time Low Change	10.23%
All Time Low Date	2026-03-30
ATR	0.78
Beta	0.62
Ch YTD	-10.01
High	17.82
High52	32.6
High52 Date	2025-05-12
High52ch	-46.77%
Low	17.29
Low52	15.74
Low52 Date	2026-03-30
Low52ch	10.23%
Ma50ch	-1.54%
Price vs 200-day SMA	-15.66%
RSI	48.62
RSI Monthly	30.18
RSI Weekly	41.68
Sharpe ratio	-1.04x
Sortino ratio	-1.15
Total Return	1%
Tr YTD	-9.96
Tr1m	4.46%
Tr1w	-0.06%
Tr3m	-19.34%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$710.4M
Operating Income Growth	-5.06
Operating Income Growth Q	-37.79
Operating Income Growth3 Y	-13.79
Operating Income Growth5 Y	-12.72
Operating margin	8.29

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	513,915,810%
Net Borrowing	-488,520,324
Shares Insiders	0.4%
Shares Institutions	100.41%
Shares Qo Q	0.19%
Shares Yo Y	0.54%
Short Ratio	3.96

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$458.9M
Average Volume	3,355.35x
Bv Per Share	8.86
CAPEX	$-399.9M
Ch1m	4.46
Ch1w	-0.06
Ch1y	-42.91
Ch3m	-19.38
Ch3y	-62.1
Ch5y	-80
Ch6m	-2.94
Change	-0.74%
Change From Open	-2.64
Close	17.48
Days Gap	1.95
Depreciation Amortization	712,242,094
Dollar Volume	105,696.2
Earnings Date	2026-04-30
EBIT	$710.4M
EBITDA	$1.4B
EPS	$-1.62
F Score	5
FCF	$547.5M
FCF EV Yield	4.41x
Financing CF	-758,062,305
Fiscal Year End	December
Founded	1,931
Goodwill	3,593,485,086
Income Tax	$358.2M
Investing CF	-421,818,885
Is Primary Listing	0
Last Earnings Date	2026-04-30
Last Report Date	2026-03-31
Ma150	19.33
Ma150ch	-10.23%
Ma20	17.78
Ma20ch	-2.42%
Net CF	-209,773,485
Next Earnings Date	2026-07-30
Open	17.82
P FCF Ratio	12.45
P OCF Ratio	7.2
Payment Date	2026-04-01
Position In Range	11.32
Ppne	2,339,909,660
Price Date	2026-05-08
Price EBITDA	$4.72
Relative Volume	2.28x
Revenue	8,572,692,600x
SBC By Revenue	1.03x
Share Based Comp	88,604,685
Tax By Revenue	4.18x
Tr6m	-2.84%
Volume	6,092
Z Score	2.41

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0QK8 dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+1.5%

$0.27 annual per share

Payout ratio

n/a

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

-18.3%

0 consecutive years of growth

Total shareholder yield

+1.0%

Next ex-dividend date: 2026-02-27

Performance

LON/0QK8 stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0QK8?

Insider, institutional, and short-interest positioning.

Institutional ownership

+100.4%

Share of float held by funds and institutions

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0QK8 momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

48.6

Neutral momentum band

Price vs 200-day MA

-15.7%

50/200-day relationship not available

Beta (5Y)

0.62

Less volatile than the market

Sharpe ratio

-1.04

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0QK8

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0QK8 stock rating?

lon/0QK8 is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0QK8 analysis?

The full report lives at /stocks/lon/0QK8/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0QK8?

The latest report frames lon/0QK8 around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0QK8 page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.